tegafur has been researched along with Scleroderma, Systemic in 2 studies
Scleroderma, Systemic: A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Here, we report the case of a patient with systemic sclerosis who developed severe digital ischemia during combination gemcitabine/S-1 chemotherapy for pancreatic cancer." | 7.77 | A case of progressive digital ischemia after early withdrawal of gemcitabine and S-1 in a patient with systemic sclerosis. ( Chiba, T; Ishikawa, S; Kanai, M; Kawaguchi, Y; Masui, T; Matsumoto, S; Mimori, T; Mori, Y; Nishimura, T; Yanagihara, K; Zaima, C, 2011) |
| " Here, we report the case of a patient with systemic sclerosis who developed severe digital ischemia during combination gemcitabine/S-1 chemotherapy for pancreatic cancer." | 3.77 | A case of progressive digital ischemia after early withdrawal of gemcitabine and S-1 in a patient with systemic sclerosis. ( Chiba, T; Ishikawa, S; Kanai, M; Kawaguchi, Y; Masui, T; Matsumoto, S; Mimori, T; Mori, Y; Nishimura, T; Yanagihara, K; Zaima, C, 2011) |
| " We report a case of a scleroderma-like reaction induced by long-term administration of UFT." | 1.31 | Scleroderma-like reaction induced by uracil-tegafur (UFT), a second-generation anticancer agent. ( Ishii, M; Kono, T; Negoro, N; Taniguchi, S, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zaima, C | 1 |
| Kanai, M | 1 |
| Ishikawa, S | 1 |
| Kawaguchi, Y | 1 |
| Masui, T | 1 |
| Mori, Y | 1 |
| Nishimura, T | 1 |
| Matsumoto, S | 1 |
| Yanagihara, K | 1 |
| Chiba, T | 1 |
| Mimori, T | 1 |
| Kono, T | 1 |
| Ishii, M | 1 |
| Negoro, N | 1 |
| Taniguchi, S | 1 |
2 other studies available for tegafur and Scleroderma, Systemic
| Article | Year |
|---|---|
A case of progressive digital ischemia after early withdrawal of gemcitabine and S-1 in a patient with systemic sclerosis.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine | 2011 |
Scleroderma-like reaction induced by uracil-tegafur (UFT), a second-generation anticancer agent.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Humans; Male; Middl | 2000 |